NSE: DRREDDY DRREDDY: Navigating the Semaglutide Wave Amidst US Headwinds – A Tale of Two Markets By StreetVantage Intelligence // May 1, 2026 ₹₹1,322.90 CAUTIOUSLY_BULLISH